カテゴリ： MarketLine, フランス, 企業調査

Electricite de France SA：企業の戦略・SWOT・財務情報

◆英語タイトル：Electricite de France SA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4483
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：58
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：フランス
◆産業分野：電力
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Electricite de France SA – Strategy, SWOT and Corporate Finance Report
Summary

Electricite de France SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Electricite de France (EDF or ‘the group’) is an integrated energy operator involved in generation, distribution and transmission of electrical energy as well as sale of natural gas. It operates in France, the UK, Italy, Belgium, Hungary, Poland, Spain, Russia, Switzerland, the Netherlands, the US, Austria, China, Laos, and Vietnam. EDF is headquartered in Paris, France.

Scope

- Detailed information on Electricite de France SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Electricite de France SA in the form of a SWOT analysis
- An in-depth view of the business model of Electricite de France SA including a breakdown and examination of key business segments
- Intelligence on Electricite de France SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Electricite de France SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Electricite de France SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Electricite de France SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Electricite de France SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Electricite de France SA: Company Overview 9
Electricite de France SA: Overview and Key Facts 9
Electricite de France SA: Overview 9
Electricite de France SA: Key Facts 9
Electricite de France SA: Key Employees 10
Electricite de France SA: Key Employee Biographies 12
Electricite de France SA: Major Products and Services 14
Electricite de France SA: Company History 15
Electricite de France SA: Locations and Subsidiaries 29
Electricite de France SA: Key Competitors 30
Electricite de France SA: Company Analysis 31
Electricite de France SA: Business Description 31
Electricite de France SA: SWOT Analysis 33
Electricite de France SA: SWOT Overview 33
Electricite de France SA: Strengths 33
Electricite de France SA: Weaknesses 35
Electricite de France SA: Opportunities 35
Electricite de France SA: Threats 36
Electricite de France SA: Corporate Financial Deals Activity 38
Electricite de France SA: Financial Deals Overview 38
Electricite de France SA: Targets and Partners 40
Electricite de France SA: Top Deals 2014 – 2018YTD* 41
Electricite de France SA: Advisors 42
Electricite de France SA: Top Legal Advisors 42
Electricite de France SA: Mergers and Acquisitions 43
Electricite de France SA: Corporate Venturing 44
Electricite de France SA: Capital Raising 45
Electricite de France SA: Partnership 46
Electricite de France SA: Divestments 47
Electricite de France SA: Recent Developments 48
Electricite de France SA: News and Events Summary 48
Electricite de France SA: Contracts 51
Electricite de France SA: Financial Deals 52
Electricite de France SA: Financial Performance 52
Electricite de France SA: Regulatory and Legal Events 52
Electricite de France SA: Strategy and Operations 53
Appendix 56
Contact Us 56
Methodology 56
About MarketLine 57

List of Tables
Table 1: Electricite de France SA: Key Facts
Table 2: Electricite de France SA: Key Employees
Table 3: Electricite de France SA: Locations and Subsidiaries
Table 4: Electricite de France SA: Key Competitors
Table 5: Electricite de France SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Electricite de France SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Electricite de France SA: M&A Average Deal Size - Value (US$m)
Table 8: Electricite de France SA: Targets and Partners
Table 9: Electricite de France SA: Top Deals 2014 - 2018YTD*
Table 10: Electricite de France SA: Legal Advisor Ranking by Value (US$m)
Table 11: Electricite de France SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Electricite de France SA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 13: Electricite de France SA: Corporate Venturing by Geography (2014 - YTD*2018)
Table 14: Electricite de France SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Electricite de France SA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Electricite de France SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Electricite de France SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Electricite de France SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Electricite de France SA: Divestments by Geography (2014 - YTD*2018)
Table 20: Electricite de France SA: News and Events Summary
Table 21: Electricite de France SA: Contracts
Table 22: Electricite de France SA: Financial Deals
Table 23: Electricite de France SA: Financial Performance
Table 24: Electricite de France SA: Regulatory and Legal Events
Table 25: Electricite de France SA: Strategy and Operations

List of Figures
Figure 1: Electricite de France SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Electricite de France SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Electricite de France SA: M&A Average Deal Size - Value (US$m)
Figure 4: Electricite de France SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Electricite de France SA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: Electricite de France SA: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 7: Electricite de France SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Electricite de France SA: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 9: Electricite de France SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Electricite de France SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Electricite de France SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 12: Electricite de France SA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Electricite de France SA：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Neomed Institute：製薬・医療：M&Aディール及び事業提携情報
    Summary Neomed Institute (Neomed) is a not-for-profit organization that provides drug discovery and development services. The organization spans its expertise in the development of small molecule therapeutics, biologics and vaccines. It offers chemistry, DMPK, fermentation and biology laboratories, …
  • Walgreens Boots Alliance, Inc.：企業の戦略・SWOT・財務情報
    Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • CiToxLAB Group：製薬・医療：M&Aディール及び事業提携情報
    Summary CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, …
  • Boston Scientific Corporation：企業のM&A・事業提携・投資動向
    Boston Scientific Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Boston Scientific Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Biocept Inc (BIOC)：企業の財務・戦略的SWOT分析
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Bio-Images Drug Delivery Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Bio-Images Drug Delivery Ltd (BDD) is an independent company that focuses on the development of modified and controlled release oral formulations. The company provides formulation development, troubleshooting, in vitro and in vivo testing and full technology transfer programs. It offers wide …
  • Nikon Corporation：企業の戦略・SWOT・財務情報
    Nikon Corporation - Strategy, SWOT and Corporate Finance Report Summary Nikon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Voya Financial Inc：企業の戦略・SWOT・財務分析
    Voya Financial Inc - Strategy, SWOT and Corporate Finance Report Summary Voya Financial Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dexia Group：戦略・SWOT・企業財務分析
    Dexia Group - Strategy, SWOT and Corporate Finance Report Summary Dexia Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Covalon Technologies Ltd (COV)-医療機器分野：企業M&A・提携分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen …
  • Capital City Bank Group Inc：企業の戦略・SWOT・財務分析
    Capital City Bank Group Inc - Strategy, SWOT and Corporate Finance Report Summary Capital City Bank Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SHV Holdings N.V.：企業の戦略・SWOT・財務情報
    SHV Holdings N.V. - Strategy, SWOT and Corporate Finance Report Summary SHV Holdings N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lake Country Power：企業の戦略的SWOT分析
    Lake Country Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • CKE Restaurants Holdings Inc.：企業の戦略・SWOT・財務分析
    CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary CKE Restaurants Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Propanc Biopharma Inc (PPCB)：製薬・医療：M&Aディール及び事業提携情報
    Summary Propanc Biopharma Inc (Propanc), formerly Propanc Health Group Corp, is a clinical stage biopharmaceutical company, which manufactures products for the treat of metastatic, pancreatic, ovarian and colorectal cancers. The company’s lead product candidate, PRP, a once-a-day intravenous formula …
  • DS Smith Plc：企業のM&A・事業提携・投資動向
    DS Smith Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DS Smith Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Providence Resources plc (PZQA)：企業の財務・戦略的SWOT分析
    Summary Providence Resources Plc (Providence Resource) is an upstream oil and gas exploration and development company that explores and develops hydrocarbon assets. The company's areas of operations include Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's basin an …
  • Evraz Plc：企業の戦略・SWOT・財務情報
    Evraz Plc - Strategy, SWOT and Corporate Finance Report Summary Evraz Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • J & J Snack Foods Corp：企業の戦略・SWOT・財務情報
    J & J Snack Foods Corp - Strategy, SWOT and Corporate Finance Report Summary J & J Snack Foods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Thar Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Thar Pharmaceuticals Inc (Thar Pharma), a subsidiary of Grunenthal GmbH is a healthcare solution provider that concentrates on transforming intravenous (IV) drugs into oral drugs for existing and new indications. The company’s lead product T121, an oral form of IV only zoledronic acid, is de …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆